Did You Know?

Editor’s Picks

Latest News

Sterna Biologicals Holds Scientific Advisory Board Meeting at 14th Congress of ECCO to Advance Phase IIb Clinical Development Program of SB012 in Ulcerative Colitis

- Meeting included international key opinion leaders - Input provided on SB012 development plan and phase IIb trial protocol MARBURG,...

Easton Announces Filing of Its Financial Statements for the Year Ended December 31, 2018 with a Revenue Increase of 145% Over 2017 and Provides General Business Update

AXT107 Restores Healthy, Non-Leaky Vasculature in the Eye by Inhibiting VEGFR2 and Activating Tie2, the Two Clinically Validated Pathways in Diseases of the Retina

AXT107 exhibited a dual mechanism of action as a monotherapy, disrupting a key component of the Vascular Endothelial Growth Factor...

Interim Analysis Showed Treatment with OPSUMIT® (macitentan) Associated with Significant Improvement in Right Ventricular (RV) Function and Pulmonary Vascular Resistance (PVR) in Patients with Pulmonary Arterial Hypertension (PAH)

error: Content is protected !!